Last reviewed · How we verify
NCT05016466
GOLD 0 - DLCO 1: A Look Beyond the Obstruction. Is Spirometry Enough for COPD (Chronic Obstructive Pulmonary Disease) Screening?
trial testing Standard Care in COPD, Chronic Obstructive Pulmonary Disease in 236 participants. Status unknown.
10 February 2025
Quick facts
| Lead sponsor | Fundación para la Investigación del Hospital Clínico de Valencia |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 236 |
| Start date | 10 September 2021 |
| Primary completion | 10 February 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Standard Care — full drug profile →
- Standard Care plus oxidative stress study plus inflammation biomarkers study
Conditions studied
- COPD, Chronic Obstructive Pulmonary Disease — all drugs for COPD, Chronic Obstructive Pulmonary Disease →
Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Who can join
Adults 18 to 99, any sex, with COPD, Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a multicenter observational prospective study in smokers or ex-smokers with cumulative exposure ≥ 10 a / p (years / pack) with respiratory symptoms and presenting a normal spirometry. The patients who sign the corresponding informed consent, will undergo a DLCO and will be divided into two groups according to the result: * Group I. Patients with DLCO \<80%. * Group II Patients with DLCO≥80%. Both groups will be followed for 5 years.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05016466
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Standard Care
Trials testing the same drug.
- NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD) · NA · not yet recruiting
- NCT06975189 — MINImising Total Radiation EXposure in Preterm Infants · Phase 2 · recruiting
- NCT07537270 — Neural Mobilization vs Cervical Neuromodulation in DPN · NA · active not recruiting
- NCT07316049 — Construction and Evaluation of an Intelligent Decision System for Reperfusion Therapy in Acute Ischemic Stroke · NA · not yet recruiting
- NCT07262840 — Health Behavior Change in High-Risk Colorectal Cancer Individuals · NA · recruiting
Other Fundación para la Investigación del Hospital Clínico de Valencia trials
Trials by the same sponsor.
- NCT06851962 — Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. · Phase 4 · active not recruiting
- NCT07291999 — Tissue Characterization in STEMI Using Cardiac MRI: a Multicenter Registry · active not recruiting
- NCT06655532 — Effects of an Exercise Program in Women Over 60 yr. With HFpEF and Sarcopenia on Functional Capacity and Quality of Life · NA · not yet recruiting
- NCT06578078 — A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients · Phase 3 · recruiting
- NCT06578520 — Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05016466 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación para la Investigación del Hospital Clínico de Valencia
- Last refreshed: 23 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05016466.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing